A staff member is photographed at Beijing Tide Pharmaceutical Co, Dec 14. The company, based in Beijing Economic-Technological Development Area (BDA), spent a total of 300 million yuan ($43.54 million) on clinical research and development of 14 products. In 2019, the company will develop three new biopharmaceutical products and invest 500 million yuan in developing a raw materials plant. [Photo/ kfqgw.beijing.gov.cn]